Go Pro

Inspira Technologies OXY B.H.N. (IINN) Competitors

Inspira Technologies OXY B.H.N. logo
$0.82 +0.02 (+2.24%)
As of 09/2/2026

IINN vs. LNSR, KEQU, LUNG, MBOT, and HYPR

Should you buy Inspira Technologies OXY B.H.N. stock or one of its competitors? Inspira Technologies OXY B.H.N.'s main competitors and comparable companies include LENSAR (LNSR), Kewaunee Scientific (KEQU), Pulmonx (LUNG), Microbot Medical (MBOT), and Hyperfine (HYPR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to LENSAR?

LENSAR (NASDAQ:LNSR) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

40.2% of LENSAR shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 65.8% of LENSAR shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than LENSAR. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 0 mentions for LENSAR. LENSAR's average media sentiment score of 0.00 equaled Inspira Technologies OXY B.H.N.'saverage media sentiment score.

Company Overall Sentiment
LENSAR Neutral
Inspira Technologies OXY B.H.N. Neutral

LENSAR presently has a consensus price target of $11.50, indicating a potential upside of 39.39%. Given LENSAR's stronger consensus rating and higher possible upside, equities research analysts clearly believe LENSAR is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LENSAR
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than LENSAR.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LENSAR$58.44M1.73-$34.28M-$0.33N/A
Inspira Technologies OXY B.H.N.$289K101.55-$13.22MN/AN/A

LENSAR has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market.

LENSAR has a net margin of 57.57% compared to Inspira Technologies OXY B.H.N.'s net margin of 0.00%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat LENSAR's return on equity.

Company Net Margins Return on Equity Return on Assets
LENSAR57.57% -529.08% 50.03%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Summary

LENSAR beats Inspira Technologies OXY B.H.N. on 8 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Kewaunee Scientific?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Kewaunee Scientific has a net margin of 3.41% compared to Inspira Technologies OXY B.H.N.'s net margin of 0.00%. Kewaunee Scientific's return on equity of 14.10% beat Inspira Technologies OXY B.H.N.'s return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Kewaunee Scientific 3.41%14.10%5.55%

Kewaunee Scientific has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K101.55-$13.22MN/AN/A
Kewaunee Scientific$282M0.37$9.62M$3.2211.43

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.05 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kewaunee Scientific
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Kewaunee Scientific beats Inspira Technologies OXY B.H.N. on 8 of the 12 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Pulmonx?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Pulmonx (NASDAQ:LUNG) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 91.0% of Pulmonx shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Comparatively, 7.5% of Pulmonx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market. Comparatively, Pulmonx has a beta of 0.34, meaning that its share price is 66% less volatile than the broader market.

Pulmonx has a consensus target price of $7.67, indicating a potential upside of 239.23%. Given Pulmonx's stronger consensus rating and higher probable upside, analysts plainly believe Pulmonx is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Pulmonx
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Pulmonx's net margin of -55.03%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Pulmonx's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Pulmonx -55.03%-96.66%-38.32%

In the previous week, Pulmonx had 9 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 11 mentions for Pulmonx and 2 mentions for Inspira Technologies OXY B.H.N.. Pulmonx's average media sentiment score of 0.91 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Pulmonx is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Pulmonx
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Pulmonx.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K101.55-$13.22MN/AN/A
Pulmonx$90.50M1.07-$54M-$1.16N/A

Summary

Inspira Technologies OXY B.H.N. and Pulmonx tied by winning 7 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Microbot Medical?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 4.7% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Microbot Medical has a consensus target price of $6.38, indicating a potential upside of 342.71%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts clearly believe Microbot Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Microbot Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Microbot Medical has lower revenue, but higher earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K101.55-$13.22MN/AN/A
Microbot MedicalN/AN/A-$13.14M-$0.24N/A

Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its share price is 116% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market.

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Microbot Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Microbot Medical N/A -21.87%-20.76%

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Microbot Medical. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 1.02 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Microbot Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Microbot Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Inspira Technologies OXY B.H.N. and Microbot Medical tied by winning 6 of the 12 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Hyperfine?

Hyperfine (NASDAQ:HYPR) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

Hyperfine presently has a consensus price target of $2.03, indicating a potential upside of 142.93%. Given Hyperfine's stronger consensus rating and higher probable upside, research analysts clearly believe Hyperfine is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperfine
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Hyperfine.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hyperfine$11.40M7.79-$35.57M-$0.38N/A
Inspira Technologies OXY B.H.N.$289K101.55-$13.22MN/AN/A

15.0% of Hyperfine shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 26.3% of Hyperfine shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Hyperfine. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Hyperfine. Hyperfine's average media sentiment score of 0.00 equaled Inspira Technologies OXY B.H.N.'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hyperfine
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Hyperfine's net margin of -210.75%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Hyperfine's return on equity.

Company Net Margins Return on Equity Return on Assets
Hyperfine-210.75% -97.88% -61.81%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Hyperfine has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its share price is 116% more volatile than the broader market.

Summary

Inspira Technologies OXY B.H.N. beats Hyperfine on 8 of the 13 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Sign up to receive the latest news and ratings for IINN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IINN vs. The Competition

MetricInspira Technologies OXY B.H.N.Healthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$29.35M$5.81B$7.26B$12.73B
Dividend YieldN/A1.76%2.53%8.86%
P/E RatioN/A25.92273.2925.38
Price / Sales101.5573.28613.4597.56
Price / CashN/A33.1477.8252.26
Price / Book13.616.0412.896.14
Net Income-$13.22M$150.03M$3.47B$349.01M
7 Day Performance-3.27%-1.32%0.60%-0.27%
1 Month Performance-19.17%1.28%5.73%0.68%
1 Year Performance-27.75%9.88%25.35%14.84%

Inspira Technologies OXY B.H.N. Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IINN
Inspira Technologies OXY B.H.N.
0.0102 of 5 stars
$0.82
+2.2%
N/A-30.2%$29.35M$289KN/A20
LNSR
LENSAR
2.2426 of 5 stars
$8.65
-3.2%
$11.50
+32.9%
-31.5%$109.84M$58.44MN/A110
KEQU
Kewaunee Scientific
1.2622 of 5 stars
$37.88
+0.6%
N/A-32.7%$108.06M$282M11.761,231
LUNG
Pulmonx
2.9154 of 5 stars
$2.50
flat
$7.67
+206.7%
+36.1%$107.37M$90.50MN/A250
MBOT
Microbot Medical
2.7202 of 5 stars
$1.52
+1.3%
$6.38
+319.4%
-59.3%$100.75MN/AN/A20

Related Companies and Tools


This page (NASDAQ:IINN) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners